
doi: 10.1038/488s7a
pmid: 22932439
Vaccines on the market aren't practical for the developing world — where cervical cancer hits hardest — but researchers are trying to make ones that are.
Drug Storage, Papillomavirus Infections, Vaccination, Immunotherapy, Active, Uterine Cervical Neoplasms, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18, Drug Design, Humans, Female, Papillomavirus Vaccines, Antigens, Viral, Developing Countries, Papillomaviridae, Immunization Schedule
Drug Storage, Papillomavirus Infections, Vaccination, Immunotherapy, Active, Uterine Cervical Neoplasms, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18, Drug Design, Humans, Female, Papillomavirus Vaccines, Antigens, Viral, Developing Countries, Papillomaviridae, Immunization Schedule
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
